Insider trade

Officer sold ~$402K of AMGN shares in the open market

Traded Aug 6, 2026 · Filed Aug 7, 2026

AmgenAMGN

~$402K
Reported value · 1,000 sh @ $402.1601: 7,340
Holds after · shares reported: +0.6%
stock since the trade · S&P 500 -0.6%, $404.85 → $407.27 on Oct 1

Why it stands out

Amgen's SVP & CCO sold $402K of Amgen shares. It happened by itself, for taxes or pay.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 6, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 7, 2026

Officer$100K–$500KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$402,160

Shares × reported transaction price

Timing vs results

2 days after results of Aug 4, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $404.85 on Aug 6, 2026, within 1% of its 52-week high, after a 15% rise over the previous 30 trading days

52-week range $271.18 (Sep 25, 2025) to $407.83 (Aug 5, 2026), 98% of the way up, from 251 adjusted closes. 30 trading days earlier: $351.43 on Jun 24, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references dividend reinvestment

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+0.5%	-0.1%	+0.6%
30 days	-6.2%	-1.4%	-4.8%

Past results only. Not a forecast.

Source receipt

Record ID: 0000318154-26-000129
Filed / recorded: Aug 7, 2026, 10:45 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: AMGEN INC
Issuer CIK: 318154
Ticker: AMGN
Reporting person: Nancy A. Grygiel
Relationship: Officer
Officer title: SVP & CCO
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Aug 6, 2026
Transaction code: S
Shares / units: 1,000
Price per share: $402.1601
Acquired / disposed: Disposed (D)
Shares owned after: 7,340
Ownership form: Direct
Amendment: No

Footnotes from the filing

Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options.
These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.